BrainFx is a leading neurofunctional assessment platform backed by clinical evidence and involved in current research programs with esteemed institutions and universities.
Most traditional paper and pencil cognitive tests were designed to pick up on more moderate to severe impairment. By focusing on more complex cognitive skills and Comprehensively assessing other areas of neurofunction, BrainFx Assessments are focused on detecting more subtle or mild to moderate dysfunction. Plus, assessments are engaging and use real world context in order to yield real world applicable insights.
Neurofunction Definition: A Comprehensive understanding of a your functional status as related to your neurological condition, whether healthy or dysfunctional. This includes the following abilities – physical, cognitive, psychosocial, activity participation, as well as your quality of life.
Jones, C., Miguel-Cruz, A., & Brémault-Phillips, S. (2021). Technology Acceptance and Usability of the BrainFx SCREEN in Canadian Military Members and Veterans With Post traumatic Stress Disorder and Mild Traumatic Brain Injury: Mixed Methods UTAUT Study. JMIR Rehabilitation And Assistive Technologies, 8(2), e26078. doi: 10.2196/26078
Overview:
Searles, C., Farnsworth II, J., Jubenville, C., Kang, M., & Ragan, B. (2018). Test-retest reliability of the BrainFx 360® performance assessment. Athletic Training and Sports Health Care, 11(4), 183- 191. doi:10.3928/01913913-20181005-01
Overview:
Sergio, L., & Gage, W. (2014). BrainFx 360 assessment: Clinical validation. York University. [White paper].
Highlights: N=22; half control; half with diagnosis.
Assessment able to predict whether healthy or with
dysfunction every time. >15
assessment
activities statistically significant between groups.
Young, K., Perlman, C., & Hewitt, K. (2018). Neurofunction in community mental health treatment: An evaluation of the clinical utility of the brainfx assessment at the Canadian mental health association waterloo wellington [White paper].
Highlights: N= approx. 250. As presented at EPION:
Assists with treatment planning and goals. Client
approved. Measures impact
of medications.
Wilansky, P., Eklund, M., Milner, T., Kreindler, D.,
Cheung, A., Kovacs, T.,…Mills, R. (2016). Cognitive
behaviour therapy for anxious and depressed youth:
Improving homework adherence through mobile
technology. Journal of Medical Internet Research,
5(4), 1-17.
doi:10.2196/resprot.5841
Team includes: CAMH, Hospital for Sick Children, Markham Stouffville Hospital, Sunnybrook Hospital, Ontario Shores for Mental Health Sciences, UOIT, University of Toronto, University of Manitoba, University of Alberta, University of Bristol, Bell Canada Chair for Mood & Anxiety Disorders, Child & Youth Mental Health Collaborative, Mood Disorders Association & Youth Speaks & Central LHIN.
Overview:
Ali, S., Bialik, C., Fang, J., Lovell, T., & Holmes, J. (2016, April). Validity of the BrainFx 360 for the assessment of standing balance. Poster presented at the meeting of Evidence-Based. Practice Conference, London.
Highlights: Psychometric properties of the balance activities in BrainFx 360 are comparable to that of the gold standard force plate.
Jerominski, A., Silverman, E., Patel, H., Volgman, A., & Aggarwal, N. (2017, April). Using technology to characterize the consequences of atrial fibrillation in female patients from the Rush Heart Center for Women (RHCW). Poster presented at the meeting of The 25th Anniversary Congress on Women’s Health, Washington.
Highlights: Utilizing BrainFx 360 Assessment, differences in functional cognitive profiles in women pre-MI and post-MI discovered
Mann, J., Bradney, D., & Bowman, T. (2018, April). The effects of environment and fatigue levels on BrainFx SCREEN scores. Poster presented at the meeting of Student Scholar Showcase, Virginia.
Highlights: BrainFx SCREEN demonstrated good
reliability regardless of whether administered in the
clinic or near the field/in
locker-room and
despite level of reported fatigue.
McWhinnie, J., Kwan, G., & Hirano, G. (2017, June). Measuring change in neurofunction with BrainFx 360 after cognitive adaptation training in schizophrenia. Poster presented at the meeting of Evidence-Based Practice Symposium Occupational Therapy, Hamilton.
Milner, T. (2013, March). The development and validation of BrainFx 360®: A tablet and web-based assessment tool for mild to moderate impairments in neurofunction. Poster presented at the meeting of Traumatic Brain Injury Conference, Washington D.C.
Highlights: >45 health professionals reviewed assessment content in detail for sensitivity to mild to moderate dysfunction.
Young, K., Hewitt, K., & Lizon, M. (2017, May). BrainFx project: Promoting mental health and participation in life activities through neurofunction. In Early Psychosis Intervention Ontario Network. In C. Cheng (Co-chair). Early Psychosis Intervention Ontario Network. Lecture conducted from Early Psychosis Intervention Ontario, Mississauga.
Young, K., Perlman, C., & Hewitt, K. (2018). Neurofunction in community mental health treatment: An evaluation of the clinical utility of the brainfx assessment at the Canadian mental health association Waterloo wellington [White paper].
Highlights: N= approx. 250. As presented at EPION: Assists with treatment planning and goals. Client approved. Measures impact of medications.
Condello, H. (2018, April). On a Mission to Eradicate Dysfunction from Brain Disorders: Our OT Journey into Digital Health. American Occupational Therapy Association National Conference, Salt Lake City, Utah.
Brain Health Screen and Risk Management Program @ Wilfred Laurier University, SE Health, Ontario Family Health Teams
Overview
Promoting Cognitive Health for Seniors within Larger Healthcare Systems @ Atrium Health (USA), West Park Healthcare, primary care partners and in partnership with the Centre for Aging and Brain Health Innovation (CABHI, powered by Baycrest) – Research in progress
Validating BrainFx DRIVE screen: A tablet-based roadside screen for detection of driving impairment due to cannabis use @ University Health Network (Toronto Rehab Institute), Apollo Applied Research (Research in Progress)
The Canadian Model of Cognitive Skills and Models of Neurofunction @ University of Alberta.
This paper will describe the development and methodology of the Canadian Model of Cognitive Skills and Models of Neurofunction which underpin the development of BrainFx Assessments.
Deep Dive into the Psychometric Properties of BrainFx Assessments @Texas State University. This study (n= ~5000) will examine the psychometric properties of the BrainFx 360 Assessment and BrainFx SCREEN using Classical Test Theory and Item Response Theory analyses. It will also examine the test equivalency between BrainFx 360 Performance Assessment and BrainFx SCREEN.
Early detection of Cognitive decline in a population at high-risk for vascular dementia using a novel digital biomarker platform (CAN U TELL) @ Wayne State University [awaiting grant funding]
This study will evaluate sensitivity of the BrainFx 360 digital biomarker to pre-clinical cognitive deficits in an at-risk population of older African Americans. It aims to determine the functional specificity of the BrainFx 360 digital biomarker with structural brain correlates and identify the health risk profile of individuals with deficits on the BrainFx 360 digital assessment.
University of California, San Diego Health Sciences. “Current screening methods miss worrisome number of persons with mild cognitive impairment.” ScienceDaily. ScienceDaily, 24 May 2016.
Elman JA et al (2018) Underdiagnosis of mild cognitive impairment: a consequence of ignoring practice effects. Alzheimers Dement (Amst) 10:372–381
This study focuses on understanding the neurological impact of Long-COVID by developing a solution that assists clinicians and researchers to better understand and address the impacts of this new and emerging phenomenon.
